Abstract |
The human T cell lymphoma Jurkat can be activated by stimuli directed either against the T cell antigen receptor-CD3 antigen complex (TcR/CD3) or the CD2 molecule. Stimulation of cells via the TcR/CD3-complex or via the CD2 molecule increases inositol phosphates and cytoplasmic free calcium. Pretreatment of Jurkat cells with cholera toxin leads to a decrease of TcR/CD3 expression on the surface of the cells, while the expression of CD2 is unaffected. In contrast to this distinct effect on the receptor expression, signaling via both pathways is inhibited by cholera toxin. The most convincing explanation for the cholera toxin-mediated inhibition of signaling is that cholera toxin interrupts the signaling pathways at a point where both, stimulation via TcR/CD3 and via CD2, use the same route. The earliest common point of the two signaling pathways, at least in the Jurkat cell line, seems to be the CD3 complex because after its down-regulation (and functional inactivation) both pathways of activation are interrupted.
|
Authors | H Sommermeyer, R Schwinzer, V Kaever, K Wessel, R E Schmidt, B Behl, K Wonigeit, M Szamel, K Resch |
Journal | European journal of immunology
(Eur J Immunol)
Vol. 19
Issue 12
Pg. 2387-90
(Dec 1989)
ISSN: 0014-2980 [Print] Germany |
PMID | 2575034
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antigens, Differentiation, T-Lymphocyte
- CD2 Antigens
- CD3 Complex
- Inositol Phosphates
- Receptors, Antigen, T-Cell
- Receptors, Immunologic
- Cholera Toxin
|
Topics |
- Antigens, Differentiation, T-Lymphocyte
(physiology)
- CD2 Antigens
- CD3 Complex
- Cell Membrane
(metabolism)
- Cholera Toxin
(pharmacology)
- Down-Regulation
(drug effects)
- Humans
- In Vitro Techniques
- Inositol Phosphates
(metabolism)
- Receptors, Antigen, T-Cell
(physiology)
- Receptors, Immunologic
(physiology)
- Signal Transduction
(drug effects)
- T-Lymphocytes
(physiology)
- Tumor Cells, Cultured
|